Open Access<p>miR- 26a Sensitizes Melanoma Cells To Dabrafenib Via Targeting HMGB1-Dependent Autophagy Pathways</p>
Author(s) -
Yan Yu,
Xiang Niu,
Min Lin,
Jinwen Huang,
Jing Zhang,
Bo Cheng,
Chao Ji
Publication year - 2019
Publication title -
drug design, development and therapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s225671
Subject(s) - dabrafenib , autophagy , hmgb1 , cancer research , melanoma , chemistry , medicine , microbiology and biotechnology , biology , apoptosis , metastatic melanoma , biochemistry , vemurafenib , receptor
Melanoma is known as the most aggressive and lethal type of cutaneous cancer due to its rapid development of drug resistance to chemotherapy drugs.